Events

Recall of Deep Brain Stimulation (DBS) Leads (implantable, neurological electrode stimulator)

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Medtronic Australasia Pty Ltd.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    RC-2013-RN-00617-1
  • Event Risk Class
    Class I
  • Event Initiated Date
    2013-06-17
  • Event Country
    Australia
  • Event Source
    DHTGA
  • Event Source URL
    https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2013-RN-00617-1
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    This is a follow up action to rc-2013-rn-00124-1. medtronic issued an urgent recall for product correction to inform surgeons of the potential for the proximal end of the dbs lead to be damaged when the connector block of the dbs lead cap twists within the assembly when turning the set screw during step 1 of dbs surgery. the damage would most likely occur at lead contact number 3 which could affect electrode contact number 3. there is a 5.0 in-oz requirement on the lead cap assembly specification. recent testing indicates that this requirement is not being met.Medtronic has implemented manufacturing process changes that address the twisting of the setscrew connector block within the lead cap and is now removing any unused product that was distributed to customers prior to implementing the change.
  • Action
    Medtronic is advising their customers that a sales representative will organise for the return of all affected stock. Surgeons are also advised that the work around instructions described in recall RC-2013-RN-00124-1 are no longer necessary for new lots of the product.

Device

Deep Brain Stimulation (DBS) Leads (implantable, neurological electrode stimulator)
  • Model / Serial
    Deep Brain Stimulation (DBS) Leads (implantable, neurological electrode stimulator)Model Number: 3387ARTG Number: 137374Model Number: 3389ARTG Number: 137138Model Number: 3391ARTG Number: 174469
  • Product Classification
    Neurological Devices
  • Manufacturer
    Medtronic Australasia Pty Ltd

Manufacturer

Medtronic Australasia Pty Ltd
  • Manufacturer Parent Company (2017)
    Medtronic plc
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    DHTGA